Holdings (as at 2026-11-10)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
First Trust NYSE® Arca® Biotechnology Index Fund 100.00%
Holdings of FBT - First Trust NYSE® Arca® Biotechnology Index Fund
(as at 2026-11-10)
Security Name % of Net Assets
Genmab A/S (ADR) 4.76%
Regeneron Pharmaceuticals, Inc. 4.00%
ADMA Biologics, Inc. 3.99%
BeOne Medicines Ltd. (ADR) 3.90%
Neurocrine Biosciences, Inc. 3.88%
Exelixis, Inc. 3.85%
argenx SE (ADR) 3.84%
TG Therapeutics, Inc. 3.79%
Alkermes Plc 3.73%
Gilead Sciences, Inc. 3.69%
Amgen Inc. 3.66%
Biogen Inc. 3.66%
Vertex Pharmaceuticals Incorporated 3.51%
United Therapeutics Corporation 3.50%
Incyte Corporation 3.48%
Bruker Corporation 3.45%
BioMarin Pharmaceutical Inc. 3.40%
NeoGenomics, Inc. 3.39%
Tarsus Pharmaceuticals, Inc. 3.29%
Bio-Techne Corporation 3.28%
Repligen Corporation 3.27%
Halozyme Therapeutics, Inc. 3.04%
Madrigal Pharmaceuticals, Inc. 2.99%
BioNTech SE (ADR) 2.94%
Axsome Therapeutics, Inc. 2.73%
Natera, Inc. 2.54%
Illumina, Inc. 2.52%
Alnylam Pharmaceuticals, Inc. 2.13%
Corcept Therapeutics Inc. 1.98%
Veracyte, Inc. 1.74%
Dreyfus Government Cash Management (Institutional Shares) 0.12%
US Dollar 0.00%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.